The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID‐19 Pandemic
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.27474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Talia Amram und 5 weiteren Autor:innen. Beteiligte Einrichtung: The School of Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Hauptthemen laut MEDLINE: Asthma, Respiratory Syncytial Virus Infections, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) infection in the first year of life has been linked with an increased risk for asthma. Some propose that RSV‐induced inflammation leads to lasting airway changes, while others contend that RSV bronchiolitis is a marker for underlying predisposition. Social distancing adopted during the COVID‐19 pandemic has led to a dramatic reduction in RSV activity, providing an unexpected opportunity to investigate this debate.
Objective
To compare the incidence of asthma‐related healthcare‐utilization (HCU) in 1–3 years of age between children born in March–June 2020 ( l ‐RSV) and children born during the same months in the years 2014–2017 (H‐RSV). Study Design and Methods This retrospective study utilized nationwide healthcare database records from Clalit‐Healthcare‐Services, the largest healthcare organization in Israel. The study analyzed asthma‐related HCU, using multivariate logistic regression and Bayesian analyses.
Results
172,463 children were included in the study: 32,927 in the l ‐RSV group versus 139,536 in the H‐RSV group. The l ‐RSV cohort showed insignificant changes and increased rates of asthma‐related HCU between 1 and 3 years of age in some asthma surrogates, compared to the H‐RSV group.
Conclusion
Reduction in RSV exposure during the first year of life did not correlate with a decrease in asthma‐related HCU. This may imply that RSV infection in infancy functions as an indicator of underlying predisposition rather than a direct cause of asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The School of Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
- The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Pediatric Pulmonary Unit, Saban Pediatric Medical Center, Soroka University Medical Center, Beer-Sheva, Israel.
- Pediatric Infectious Diseases Unit, Saban Pediatric Medical Center, Soroka University Medical Center, Beer Sheva, Israel.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Amram, T., Duek, O. A., Golan-Tripto, I., Goldbart, A., Greenberg, D., & Hazan, G. (2025). The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID‐19 Pandemic. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27474
Vancouver
Amram T, Duek OA, Golan-Tripto I, Goldbart A, Greenberg D, Hazan G. The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID‐19 Pandemic. Pediatric Pulmonology. 2025. doi:10.1002/ppul.27474
BibTeX
@article{Amram2025,
author = {Amram, Talia and Duek, Or A and Golan-Tripto, Inbal and Goldbart, Aviv and Greenberg, David and Hazan, Guy},
title = {The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID‐19 Pandemic},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.27474}
}
EUVIMED